Loading clinical trials...
Loading clinical trials...
An Open-label Extension Study to Assess the Long-term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
Conditions
Interventions
Xanomeline and Trospium Chloride Capsules
Locations
175
United States
Alea Research
Phoenix, Arizona, United States
Pillar Clinical Research LLC
Little Rock, Arkansas, United States
Woodland International Research Group, LLC
Little Rock, Arkansas, United States
Advanced Research Center, Inc.
Anaheim, California, United States
CITrials - Bellflower
Bellflower, California, United States
Local Institution - 110
Cerritos, California, United States
Start Date
March 7, 2022
Primary Completion Date
March 19, 2026
Completion Date
March 19, 2026
Last Updated
March 11, 2026
NCT06894212
NCT04226898
NCT05240976
NCT06745479
NCT07455929
NCT06740383
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
CONTACT
855-907-3286Clinical.Trials@bms.comFirst line of the email MUST contain the NCT# and Site #.
CONTACT
Lead Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions